Triglimniv 2mg/500mg/15mg Tablet
Marketer
Nivulia Lifesciences Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Triglimniv 2mg/500mg/15mg Tablet
Glimepiride-Metformin-Pioglitazone 2mg/500mg/15mg tablets offer combined blood sugar management. This medication, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, reducing blood glucose. Adhere strictly to your physician's prescribed dosage and regimen. Take with food to prevent digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, skip the missed dose. Never double the dose; overdose risks hypoglycemia. Concurrent use with other diabetes medications, alcohol, or meal skipping increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions should be disclosed to your doctor before initiating treatment. Pregnant or lactating individuals require medical consultation. Kidney function tests are mandatory before commencing this therapy. Limit alcohol consumption to minimize side effect potential.
Uses of Triglimniv 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Triglimniv 2mg/500mg/15mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Triglimniv 2mg/500mg/15mg tablet with a meal.
Common Side effects of Triglimniv 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Triglimniv 2mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the Triglimniv 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.
How Triglimniv 2mg/500mg/15mg Tablet works:
Triglimniv 2mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone, three antidiabetic agents with distinct actions. This triple combination improves blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Triglimniv 2mg/500mg/15mg tablets is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Triglimniv 2mg/500mg/15mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The use of Triglimniv 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Triglimniv 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Triglimniv 2mg/500mg/15mg tablet use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Triglimniv 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Triglimniv 2mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Triglimniv 2mg/500mg/15mg Tablet :
Should you forget a Triglimniv 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triglimniv 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently